Potential use of biological proteins for liver failure therapy

Kazuaki Taguchi, Keishi Yamasaki, Hakaru Seo, Masaki Otagiri

研究成果: Review article

9 引用 (Scopus)

抜粋

Biological proteins have unlimited potential for use as pharmaceutical products due to their various biological activities, which include non-toxicity, biocompatibility, and biodegradability. Recent scientific advances allow for the development of novel innovative protein-based products that draw on the quality of their innate biological activities. Some of them hold promising potential for novel therapeutic agents/devices for addressing hepatic diseases such as hepatitis, fibrosis, and hepatocarcinomas. This review attempts to provide an overview of the development of protein-based products that take advantage of their biological activity for medication, and discusses possibilities for the therapeutic potential of protein-based products produced through different approaches to specifically target the liver (or hepatic cells: hepatocytes, hepatic stellate cells, liver sinusoidal endothelial cells, and Kupffer cells) in the treatment of hepatic diseases.

元の言語English
ページ(範囲)255-274
ページ数20
ジャーナルPharmaceutics
7
発行部数3
DOI
出版物ステータスPublished - 2015 8 31
外部発表Yes

ASJC Scopus subject areas

  • Pharmaceutical Science

フィンガープリント Potential use of biological proteins for liver failure therapy' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用